The search for an ideal cardiac valve substitute continues. Homografts have the advantages of resistance to infection, superior hemodynamic profile, and avoidance of anticoagulation compared to the conventional prosthetic valves (1). However, their durability and availability are a concern.
At this center, the donor selection, procurement, sterilization, and preservation process is based on the recommendations in the guiding document by the American Association of Tissue Banks and the statutory provisions of the 1994 Transplantation of Human Organs and Tissues Act (THOTA) (2, 3).
Disclaimer
The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.
558 views on Vimeo
